Skip to main content

AZN · Astrazeneca PLC · Analyst Estimates

Track AZN — free
$156.90 -0.80 (-0.51%) At close · Oct 2
Market Cap
$254.67B
Shares
1.55B
Volume · Oct 2 3.04M Avg daily vol (3M) 3.41M

Analyst Estimates

Compare analyst forecasts for Astrazeneca PLC across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-10-01 13:41 UTC · Publication dates shown per estimate · 12 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
10.03
10.085
10.14
—
10.085
7.63537
10.05333
6.86321
— — — —
EPS
analysts
Publication date not stated
— — —
2
— — — —
0
0
0
0
Revenue
USD
Publication date not stated
58972079610
63171995870
64354000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
27
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
11.38
11.58
11.78
—
11.58
8.77564
11.36
8.04268
— — — —
EPS
analysts
Publication date not stated
— — —
2
— — — —
0
0
0
0
Revenue
USD
Publication date not stated
62900252480
67008063050
68647000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
27
— — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
Revenue
USD
Publication date not stated
15775000000
16077025700
16319300000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
11
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
Revenue
USD
Publication date not stated
16185000000
16715665130
17085720600
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
11
— — — — — — — —
Key facts CIK 901832 CUSIP G0593M107 13F (30d) 27 filings 23 filers Visit website Investor relations